fluarix: Clinical Trials

7 trials of fluarix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 7

Follow fluarix: new trials by email Literature Review of fluarix trials Research Report on fluarix

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
Flublok, Flucelvax, Fluarix - Influenza
Phase 4CompletedCenters for Disease Control and Prevention9442018-09-122024-07-22
Influenza Vaccine Feasibility Study in Children With Persistent Asthma
ccIIV4, IIV4 - Asthmatic
Phase 4CompletedVanderbilt University Medical Center402016-10-102018-04-23
Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military
Seasonal trivalent influenza vaccine, Anflu®, Seasonal trivalent influenza vaccine, VAXIGRIP, Seasonal trivalent influenza vaccine, Fluarix - Influenza
Phase 4CompletedCenter for Disease Prevention and Control of Beijing Military Region2922014-10-012015-12-29
Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old
Prepandrix™, Fluarix™ - Influenza
Phase 4CompletedGlaxoSmithKline1312012-12-052018-09-07
Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™
Fluarix™, Havrix™ Junior - Influenza
Phase 4CompletedGlaxoSmithKline1622010-09-152018-09-24
Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status
Fluarix - Influenza
Phase 4CompletedPublic Health England1002007-03-012018-08-29
Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™
Fluarix™ - Influenza
Phase 4CompletedGlaxoSmithKline30542006-10-052018-10-09

Conditions studied

Influenza, Human (6)  ·  Asthma (1)

Sponsors

GlaxoSmithKline (3)  ·  Center for Disease Prevention and Control of Beijing Military Region (1)  ·  Centers for Disease Control and Prevention (1)  ·  Public Health England (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (3)  ·  Netherlands (2)  ·  China (1)  ·  Germany (1)  ·  Poland (1)  ·  South Korea (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Brendan Flannery, PhD (1)  ·  Dongqi Gao, PhD (1)  ·  Elizabeth Miller, MBBS FRCPath (1)  ·  Fatimah Dawood, MD (1)  ·  Kathryn M Edwards, MD (1)

Results publications

PMID 25910919, PMID 26069949, PMID 34245243, PMID 36031405, PMID 38177116